Rodman & Renshaw - May 2011 Report

22nd Century Ltd, LLC (OTCBB: XXII; Twitter: $XXII) is a plant biotechnology company whose proprietary technology allows for the level of nicotine (and other nicotinic alkaloids) in the tobacco plant to be decreased or increased through genetic engineering and breeding. The company owns or exclusively controls 98 issued patents in 79 countries where at least 75% of the world's smokers reside. 22nd Century's business segments are primarily smoking cessation products and modified risk tobacco products. 22nd Century is committed to developing and commercializing the worlds most effective and acceptable smoking cessation aid and, for those smokers who do not wish to quit smoking, consumer acceptable modified risk tobacco products that reduce exposure to smoke toxins compared to conventional cigarettes.